Avid Bioservices Inc (CDMO)

[wxcbs]

According to IR when asked: Will Stason being doing any of their own trials or will they be using data from our trials?:
We expect Stason to use the clinical data already available to expedite the development of Cotara, but we’re not privy to the details of their development plans in the certain APEC countries covered under our agreement.

Our clinical development for Cotara includes an ongoing Phase II trial, which we recently expanded to include U.S. sites, and we plan to report results from a prior Phase I trial at the ASCO Annual Meeting in June.

Regards,
Amy
Amy Figueroa | Senior Director of Investor Relations & Corporate Communications

Hard to believe it was only 2 years ago we presented this data for the second time.. Now we're presenting it for the 3rd time.

Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara for the Treatment of Brain Cancer
CHICAGO and TUSTIN, Calif., May 31, 2008 /PRNewswire-FirstCall/

Read more: http://www.drugs.com/clinical_trials/data-presented-asco-supports-potential-peregrine-s-cotara-br ain-cancer-4529.html#ixzz0n40ZBDx1

11 years since we first presented Phase I data at ASCO
M2 PRESSWIRE-19 May 1999-TECHNICLONE: Techniclone announces results from Phase I study with Cotara at American Society of Clinical Oncology (C)1994-99 M2 COMMUNICATIONS LTD
http://www.encyclopedia.com/doc/1G1-54683988.html


Let's not forget we've presented Phase II data in 2001 and now we're back with Phase I.
http://www.highbeam.com/doc/1G1-74497138.html